Physician

Joshua Daniel Rosenberg, MD

According to 2025 Medicare claims, Joshua Rosenberg, MD (NPI: 1124280896) practices hematology/oncology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 93003-5569. Rosenberg is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Rosenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 509 traditional Medicare patients, billed 145,178 HCPCS/CPT codes, and received $3,015,660 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,054 prescription claims across 178 beneficiaries totaling $3,889,192 in drug costs, led by Revlimid (Lenalidomide). DME data shows 13 claims. Open Payments data shows 1 records totaling $525. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,561 to $3,015,660. Similarly, Part D prescription costs have moved sharply higher in recent years, from $119,980 to $3,889,192. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $28,561 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $156,845 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,080,087 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,869,182 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,359,630 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,630,298 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,375,871 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,963,072 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,576,526 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,015,660 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201570327$28,561
20161169,474$156,845
201717260,792$1,080,087
201824683,951$1,869,182
2019384115,711$2,359,630
2020436136,634$2,630,298
202136059,009$1,375,871
202239796,093$1,963,072
2023443139,990$2,576,526
2024509145,178$3,015,660

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.9M2015 Drug cost: $119,980 (USD; Tot_Drug_Cst)2016 Drug cost: $333,594 (USD; Tot_Drug_Cst)2017 Drug cost: $613,206 (USD; Tot_Drug_Cst)2018 Drug cost: $748,805 (USD; Tot_Drug_Cst)2019 Drug cost: $1,262,446 (USD; Tot_Drug_Cst)2020 Drug cost: $1,986,039 (USD; Tot_Drug_Cst)2021 Drug cost: $1,748,780 (USD; Tot_Drug_Cst)2022 Drug cost: $2,818,111 (USD; Tot_Drug_Cst)2023 Drug cost: $2,471,326 (USD; Tot_Drug_Cst)2024 Drug cost: $3,889,192 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201548268$119,980
201646210$333,594
201749323$613,206
201886492$748,805
2019116630$1,262,446
2020123806$1,986,039
202196474$1,748,780
2022111757$2,818,111
2023139880$2,471,326
20241781,054$3,889,192

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.0K$4.1K2019 Medicare payment: $4,092 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,155 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,849 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $201 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R46$4,092
2020N/RN/RN/R
2021N/R12$1,155
2022N/R51$1,849
2023N/RN/RN/R
2024N/R13$201

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more159605$146
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more234460$99
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's312732$13
36415Insertion of needle into vein for collection of blood sample158346$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count255939$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide511,337$978,568
TagrissoOsimertinib Mesylate23690$370,314
LenalidomideLenalidomide27735$338,916
VenclextaVenetoclax17510$253,802
BrukinsaZanubrutinib15450$225,410

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R13$201

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$525AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Daniel Rosenberg, MD?

Tedicare shows public-source Medicare data for Joshua Daniel Rosenberg, MD (NPI 1124280896), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Daniel Rosenberg, MD have ACO affiliation data?

Joshua Daniel Rosenberg, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Joshua Daniel Rosenberg, MD?

Joshua Daniel Rosenberg, MD is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1235107566) in the available physician profile data.

Does Joshua Daniel Rosenberg, MD have Open Payments data?

Joshua Daniel Rosenberg, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.